{"schema_version":"secwatch.filing_event.v1","accession":"0001670541-25-000123","form_type":"8-K","ticker":"ADNT","cik":"0001670541","company_name":"Adient plc","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.088856+00:00","generated_at":"2026-05-17T00:19:05.214038+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adient Q4 net income falls to $18M; full-year loss of $281M on $333M goodwill impairment","bullets":["Q4 net sales $3,688M (+3.5% YoY); net income attributable to Adient $18M ($0.22 diluted EPS) vs $79M ($0.91).","FY2025 net loss attributable to Adient $281M vs income $18M prior year; includes $333M goodwill impairment.","Q4 adjusted EBITDA $226M (6.1% margin) vs $235M (6.6%); full-year adjusted EBITDA $881M (6.1%) vs $880M.","Americas Q4 adjusted EBITDA $111M (6.2% margin) down from $116M (6.7%); EMEA improved to $31M from $28M.","Free cash flow FY2025 $204M vs $277M; net leverage ratio 1.63x vs 1.66x year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001670541-25-000123","json":"https://secwatch.observer/filing/0001670541-25-000123.json","markdown":"https://secwatch.observer/filing/0001670541-25-000123.md","text":"https://secwatch.observer/filing/0001670541-25-000123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1670541/000167054125000123/0001670541-25-000123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1670541/000167054125000123/adnt-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:19:05.214038+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}